Procter & Gamble Hygiene and Health Care LimitedPGHHCorporate

Consumer Defensive Household & Personal Products Latest results: Dec 2025 2 quarters of data
₹7,169.00
MCap ₹23,271 Cr
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹1,262 Cr
Sales · Dec 2025
₹402 Cr
Operating Profit · Dec 2025
31.8%
OPM % · Dec 2025
₹301 Cr
Net Profit · Dec 2025
₹92.87
EPS · Dec 2025

📝 Procter & Gamble Hygiene and Health Care Limited — results explained

Quarter ended December 2025 (Q3 FY26)

Procter & Gamble Hygiene and Health Care Limited reported revenue of ₹1,262 crore for the quarter ended December 2025 (Q3 FY26).

Net profit stood at ₹301 crore. Earnings per share (EPS) came in at ₹92.87.

Operating profit stood at ₹402 crore — an operating margin (OPM) of 31.8%.

Valuation snapshot

At the current price of ₹7,169.00, PGHH has a market capitalisation of ₹23,271 crore.

Within the Household & Personal Products industry, it is the 7th-largest of the 9 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 70.64%, foreign institutional investors (FIIs) 0.62%, domestic institutional investors (DIIs) 15.04%, public shareholders 13.70% of Procter & Gamble Hygiene and Health Care Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹23,271 Cr
Current Price ?
₹7,169.0
P/E ?
N/A
Industry P/E ?
35.30
P/B ?
30.90
P/S ?
N/A
P/FCF ?
26.06
Enterprise Value ?
₹23,272 Cr
EV/EBITDA ?
N/A
PEG ?
N/A
Earnings Yield ?
N/A
Dividend Yield ?
N/A
Profitability & Returns
Sales (TTM) ?
N/A
OPM ?
N/A
Profit after tax (TTM) ?
N/A
EPS (TTM) ?
N/A
ROCE ?
157.0%
ROE ?
N/A
ROA ?
N/A
Growth
Sales — latest qtr ?
₹1,262 Cr
PAT — latest qtr ?
₹301 Cr
YoY qtr sales growth ?
N/A
YoY qtr profit growth ?
N/A
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹1 Cr
Debt to Equity ?
0.00
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
70.64%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-17.8%
Return 6 months ?
-28.3%

🗓️ Quarterly results (2 quarters · ₹ Cr)

same fiscal quarter as Dec bestweakest per row · for costs (interest, NPAs) low is best
Metric Jun 2025Dec 2025 YoY % QoQ %
Sales 9371,262 — —
Operating Profit 266402 — —
Other Income 812 — —
Interest 03 — —
Depreciation 910 — —
Profit Before Tax 265402 — —
Net Profit 192301 — —
EPS 59.1792.87 — —
OPM % 28.4% 31.8% — —

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric Jun 2023Jun 2024Mar 2025Mar 2026 % Chg
Equity Capital 32323232 +0.0%
Reserves 914742705721 +2.3%
Borrowings 4321 -50.0%
Other Liabilities 1,1871,0811,0151,049 +3.3%
Total Liabilities 2,1371,8591,7551,804 +2.8%
Fixed Assets 170139131163 +24.4%
CWIP 23284121 -48.8%
Investments 0000 —
Other Assets 1,9451,6921,5831,619 +2.3%
Total Assets 2,1371,8591,7551,804 +2.8%

💧 Cash Flow (latest 4 periods)

Metric Jun 2023Jun 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 826470593924 +55.8%
Cash from Investing Activity -101-3411 +132.4%
Cash from Financing Activity -477-861-666-845 -26.9%
Net Cash Flow 339-390-10791 +185.0%
Free Cash Flow 781427539893 +65.7%
CFO/OP 121%79%96%105% +9.4%

➗ Ratios (latest 4 periods)

Metric Jun 2023Jun 2024Mar 2025Mar 2026 % Chg
Debtor Days 20213321 -36.4%
Inventory Days 48516451 -20.3%
Days Payable 213193235197 -16.2%
Cash Conversion Cycle -145-121-138-126 +8.7%
Working Capital Days -53-32-31-31 +0.0%
ROCE % 101%112%104%157% +51.0%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 70.64%70.64%70.64%70.64%70.64% +0.0%
FIIs 1.38%1.11%1.06%0.97%0.62% -36.1%
DIIs 15.49%16.05%16.03%15.96%15.04% -5.8%
Public 12.48%12.19%12.25%12.43%13.70% +10.2%
No. of Shareholders 47,89149,99750,96953,41664,415 +20.6%

⚖️ Peer comparison

Industry: Household & Personal Products · 9 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 HINDUNILVR Hindustan Unilever ₹1,927.00 452,766 30.3 66,374 14,971 23.1% 22.6% 3.8% 41.1% 5.0% -3.2%
2 MARICO Marico ₹802.10 104,111 59.0 13,611 1,813 17.1% 13.3% 35.1% 21.3% 22.1% 18.3%
3 GODREJCP Godrej Consumer ₹865.00 88,516 46.2 16,050 1,914 20.3% 11.9% 7.8% 0.5% 15.4% 11.5%
4 DABUR Dabur India ₹376.00 66,701 33.8 13,552 1,947 18.6% 14.4% 5.0% 7.3% 10.6% 15.3%
5 COLPAL Colgate-Palmolive (India) ₹1,797.40 48,887 36.3 6,204 1,348 30.6% 21.7% -0.1% -7.7% 11.8% 6.9%
6 CUPID Cupid ₹279.70 37,610 272.6 470 137 37.9% 29.1% 104.5% 165.2% 158.7% 194.1%
7 PGHH Procter & Gamble ₹7,520.00 24,410 30.9 4,244 790 25.3% 18.6% -0.4% 19.2% -4.9% -34.3%
8 GILLETTE Gillette India ₹7,305.00 23,804 35.6 3,176 668 30.3% 21.0% 7.6% 22.7% 10.8% 9.2%
9 EMAMILTD Emami ₹364.30 15,902 21.2 3,915 750 24.9% 19.2% -0.8% -3.4% 14.9% -15.4%
❓ Frequently asked questions
What was Procter & Gamble Hygiene and Health Care Limited's revenue in Q3 FY26?
Procter & Gamble Hygiene and Health Care Limited reported revenue of ₹1,262 crore for the quarter ended December 2025 (Q3 FY26).
What was Procter & Gamble Hygiene and Health Care Limited's net profit in Q3 FY26?
Net profit stood at ₹301 crore. Earnings per share (EPS) came in at ₹92.87.
What is PGHH's market capitalisation and P/E ratio?
At the current price of ₹7,169.00, PGHH has a market capitalisation of ₹23,271 crore.
Who owns Procter & Gamble Hygiene and Health Care Limited? (shareholding pattern)
As of Sep 2026, promoters held 70.64%, foreign institutional investors (FIIs) 0.62%, domestic institutional investors (DIIs) 15.04%, public shareholders 13.70% of Procter & Gamble Hygiene and Health Care Limited.
TTM ends N/A. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI